Shekhar Saurav, Singh Raj Bahadur, De Ranjeet Rana, Singh Ritu, Kumar Nitin
Department of Anaesthesiology (Trauma and Emergency), Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
Anesth Essays Res. 2022 Jan-Mar;16(1):7-11. doi: 10.4103/aer.aer_22_22. Epub 2022 May 31.
Patients with acute brain injury presents are unique subset of neurocritical care patients with its long-term functional prognosis difficult to determine. They often have long intensive care unit (ICU) stay and presents as challenge to decide when to transfer out of ICU. This prospective study aims to assess the benefits of early tracheostomy in terms of ICU-length of stay (ICU-LOS), number of days on ventilator (ventilator days), incidence of ventilator-associated pneumonia (VAP), and mortality rates.
After institutional ethical clearance, 80 patients were randomized into two groups: Group A, early tracheostomy group (tracheostomy within 3 days of intubation) and Group B, standard of care group (tracheostomy after 10 days of intubation: late tracheostomy). A cutoff of 10 in the SET score was used in predicting need of early tracheostomy; both groups were compared with respect to ICU-LOS, number of ventilator days (ventilation time), need of analgesia and sedation, incidence of VAP, and mortality data.
Both the groups were comparable in terms of demographic profile and various disease severity scores. ICU-LOS was 14.9 ± 3.6 days in Group A and 17.2 ± 4.6 in Group B. The number of days on ventilator and incidence of VAP was significantly lower in Group A as compared to Group B. There was significantly lower mortality in Group A subset of patients in ICU.
SET score is a simple and reliable score with fair accuracy and high sensitivity and specificity in predicting need of tracheostomy in neurocritical patients. A cutoff of 10 in the score can be reliably used in predicting need of early tracheostomy as in few other studies. Early tracheostomy is clearly advantageous in neurocritical patients, but has no advantage in terms of long-term mortality rates.
急性脑损伤患者是神经重症监护患者中的一个独特亚组,其长期功能预后难以确定。他们通常在重症监护病房(ICU)停留时间较长,决定何时转出ICU是一项挑战。这项前瞻性研究旨在评估早期气管切开术在ICU住院时间(ICU-LOS)、呼吸机使用天数、呼吸机相关性肺炎(VAP)发生率和死亡率方面的益处。
经机构伦理批准后,80例患者被随机分为两组:A组为早期气管切开组(插管后3天内进行气管切开)和B组为标准治疗组(插管后10天进行气管切开:晚期气管切开)。SET评分以10分为界值来预测早期气管切开的需求;比较两组在ICU-LOS、呼吸机使用天数(通气时间)、镇痛和镇静需求、VAP发生率和死亡率数据方面的情况。
两组在人口统计学特征和各种疾病严重程度评分方面具有可比性。A组的ICU-LOS为14.9±3.6天,B组为17.2±4.6天。与B组相比,A组的呼吸机使用天数和VAP发生率显著更低。A组患者在ICU中的死亡率显著更低。
SET评分是一个简单可靠的评分,在预测神经重症患者气管切开需求方面具有相当的准确性以及高敏感性和特异性。与其他一些研究一样,可以可靠地使用10分的界值来预测早期气管切开的需求。早期气管切开对神经重症患者显然有利,但在长期死亡率方面并无优势。